Search research articles
Contact Us
Filters
Showing results (631-640 of 640) with videos related to
Page
of 64
Sort By:
You have reached the last page of results.
This site can display upto 640 results.
Critical Care (London, England)
|
November 9, 2021
The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study
Carol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 8, 2022
Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non-COVID-19 Critical Illness
Carol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
Nature Medicine
|
January 9, 2023
Autologous T cell therapy for MAGE-A4<sup>+</sup> solid cancers in HLA-A*02<sup>+</sup> patients: a phase 1 trial
David S Hong, Brian A Van Tine, Swethajit Biswas, et al.
American Journal of Epidemiology
|
May 27, 2017
Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis
Ellie Paige, Jessica Barrett, Lisa Pennells, et al.
Research Square
|
September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial
Wungki Park, Catherine O'Connor, Joanne Chou, et al.
JAMA
|
July 17, 2012
Lipid-related markers and cardiovascular disease prediction
, Emanuele Di Angelantonio, Pei Gao, et al.
Nature Medicine
|
March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial
Wungki Park, Catherine A O'Connor, Joanne F Chou, et al.
The New England Journal of Medicine
|
October 5, 2012
C-reactive protein, fibrinogen, and cardiovascular disease prediction
, Stephen Kaptoge, Emanuele Di Angelantonio, et al.
European Heart Journal
|
November 27, 2018
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies
Lisa Pennells, Stephen Kaptoge, Angela Wood, et al.
European Journal of Epidemiology
|
September 19, 2007
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases
, J Danesh, S Erqou, et al.
Page
of 64
Search research articles
Search
Showing results (631-640 of 640) with videos related to
Sort By:
Page
of 64
You have reached the last page of results.
This site can display upto 640 results.
Critical Care (London, England)
|
November 9, 2021
The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study
Carol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 8, 2022
Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non-COVID-19 Critical Illness
Carol L Hodgson, Alisa M Higgins, Michael J Bailey, et al.
Nature Medicine
|
January 9, 2023
Autologous T cell therapy for MAGE-A4<sup>+</sup> solid cancers in HLA-A*02<sup>+</sup> patients: a phase 1 trial
David S Hong, Brian A Van Tine, Swethajit Biswas, et al.
American Journal of Epidemiology
|
May 27, 2017
Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis
Ellie Paige, Jessica Barrett, Lisa Pennells, et al.
Research Square
|
September 15, 2025
Pembrolizumab and Olaparib (POLAR) Maintenance Therapy in Metastatic Pancreatic Cancer With or Without Homologous Repair Deficiency: A Biomarker Selected Phase II Trial
Wungki Park, Catherine O'Connor, Joanne Chou, et al.
JAMA
|
July 17, 2012
Lipid-related markers and cardiovascular disease prediction
, Emanuele Di Angelantonio, Pei Gao, et al.
Nature Medicine
|
March 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial
Wungki Park, Catherine A O'Connor, Joanne F Chou, et al.
The New England Journal of Medicine
|
October 5, 2012
C-reactive protein, fibrinogen, and cardiovascular disease prediction
, Stephen Kaptoge, Emanuele Di Angelantonio, et al.
European Heart Journal
|
November 27, 2018
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies
Lisa Pennells, Stephen Kaptoge, Angela Wood, et al.
European Journal of Epidemiology
|
September 19, 2007
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases
, J Danesh, S Erqou, et al.
Page
of 64